We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Teva Snaps Up Compliance Tracking Startup Gecko

By HospiMedica International staff writers
Posted on 04 Oct 2015
Print article
Teva Pharmaceutical Industries (Teva; Petah Tikva, Israel) has acquired respiratory disease compliance startup Gecko Health Innovations (Gecko; Cambridge, MA, USA) for an undisclosed sum.

The purchase positions Teva with in-house medication compliance tracking capabilities for consumer use, leveraging a technology largely reserved for clinical trials into one available for everyday use by its customers. Gecko, founded in 2012, has focused so far on chronic obstructive pulmonary disease (COPD) and asthma compliance via its flagship product, CareTRx, which is comprised of a hardware device which attaches to most metered-dose inhalers (MDIs), as well as a software program which synchronizes and stores data through an app-based user interface to the cloud.

Together with Gecko Health Innovations, Teva will further explore new ways to apply the CareTRx technology to its robust pipeline and portfolio of respiratory products, with the goal of enhancing clinical outcomes for patients. The purchase also takes out of play one of a handful of high-profile startups in the medical compliance market, which include Propeller Health (Madison, WI, USA), whose sensor and digital health platform were approved for use with the in GlaxoSmithKline (GSK; London, United Kingdom) Diskus dry powder inhaler for asthma and COPD.

“The acquisition of Gecko Health Innovations further enhances Teva's ability to develop and deliver truly patient-centered solutions by utilizing eConnected, data-driven technology to improve the management of respiratory diseases,” said Rob Koremans, MD, President and CEO of Teva Global Specialty Medicines.

“During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families,” said Yechiel Engelhard, MD, CEO and Founder of Gecko Health Innovations. “Our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva's focus on innovative patient solutions.”

Related Links:

Teva Pharmaceutical Industries
Gecko Health Innovations
Propeller Health


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Ventilator
TRventi-3D

Print article

Channels

Critical Care

view channel
Image: A machine learning tool can identify patients with rare, undiagnosed diseases years earlier (Photo courtesy of 123RF)

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

Patients suffering from rare diseases often endure extensive delays in receiving accurate diagnoses and treatments, which can lead to unnecessary tests, worsening health, psychological strain, and significant... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.